Execs On The Move: Bausch & Lomb And Stille Both Appoint New CEOs In March
An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.
More from Leadership
More from Medtech Insight
• By
Point of care ultrasound technology that can be used by non-sonographers will plug gaps in workforce coverage and bring new critical care capabilities to the frontline of care, said Royal Philips.
• By
The new AI Precision Medicine platform supports the company’s flagship product, EvoLiver, which received US FDA breakthrough device designation in April.
• By
16 June marked the first major new regulatory instrument in the UK’s post-Brexit transition to a standalone device regulatory system for Great Britain.